By Ameen Kamal, Head of Science & Technology at EMIR Research,
News of a vaccine breakthrough from Pfizer Inc. and BioNTech SE on its mRNA-type BNT162b2 vaccine achieving 90% effectiveness have stirred positive reactions as many see this as a significant light at the end . . .
Please Login to read all contents for free.